Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Low-dose oral minoxidil effectively treats hair loss with good tolerance.

Scientists developed a new method to deliver alopecia treatment directly to hair follicles, which could be a promising treatment for hair loss and other hair diseases.

Finasteride is more effective and satisfactory than montelukast for treating moderate acne in women.

Testosterone reduces knee movement, while flutamide and finasteride increase it.

Niosomes improve minoxidil skin delivery for hair loss treatment.

Testosterone reduces, while finasteride enhances, morphine's pain relief.

Cabergoline is more effective and has fewer side effects than bromocriptine for treating women with hyperprolactinemic amenorrhea.

Low-dose oral minoxidil improved hair growth when topical treatments failed.

Low-dose oral and sublingual minoxidil seem safe for children with hair disorders.

Sublingual and oral minoxidil are equally effective for hair growth, but sublingual causes fewer palpitations.

Cyclosporine starts hair growth faster, while minoxidil makes it last longer.

A 70% black ear mushroom extract hair tonic effectively stops M. furfur growth.

Combining two treatments for hair loss works better than using just one.

Minoxidil can treat female hair loss but may cause side effects.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

PPCM microspheres allow controlled finasteride release over 24 hours.

Finasteride treatment can decrease certain steroids and increase others, possibly leading to depression symptoms in some cases.

Lipo-minoxidil increases VEGF expression more than regular minoxidil.

Progesterone reduces anxiety and depression in female mice by increasing BDNF in the brain, needing 5α-reduction and estradiol.

The study identified a key protein involved in producing underarm odor and found ways to inhibit it.

A new method was developed to make a compound used in finasteride and epristeride with a 69% yield.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

Minoxidil promotes hair growth by delaying the hair's resting phase.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

MXD@CP could be a promising new topical treatment for hair loss.

Melatonin treatment may increase cashmere production in Spanish goats.

Oral minoxidil effectively increases hair growth in male baldness but can cause side effects like excessive hair growth and swelling.